Founded in 2015, IDEAYA Biosciences Inc. is a clinical-stage oncology company focused on developing targeted therapeutics for rare molecularly defined cancers. With a strong pipeline and partnerships with top pharmaceutical companies like Novartis, IDEAYA is poised to make significant contributions to the advancement of personalized medicine in the field of oncology.
Notification